Effects of bovine casein hydrolysate as a dry cow therapy on prevention and cure of bovine intramammary infection,

Abstract

The objectives were to investigate the efficacy of bovine casein hydrolysate (bCNH) as a dry cow therapy on: 1) preventing new intramammary infection (IMI) postpartum of all bacteria and coagulase-negative staphylococci (CNS); 2) curing existing subclinical infections, mainly of CNS; and 3) affecting on milk yield, composition and somatic cell count (SCC) during the post-calving lactation.